Skip to main content
. 2023 Apr 4;13(7):1339. doi: 10.3390/diagnostics13071339

Table 2.

Potassium overdose cases in the literature with doses and/or ante-mortem K+ concentration 1 reported.

Author
(Case No)
K+ Dose
(mEq/L)
RoA AM K+ cc
(mEq/L)
Survived
(Yes/No)
Watanabe (a) [6] 55 IV N/A No
Watanabe (b) [6] IV N/A No
Wetherton (a) [5] 40 IV N/A No
Wetherton (b) [5] 26.4 IV N/A No
Wetherton (c) [5] N/A IV 12.4 No
Chaturwedi [16] 14.68 IV N/A No
Restuccio [8] 283 oral 9.6 No
Saxena [9] 800 oral SR 9.6 No
Kaplan [11] 540–720 oral N/A No
Wetli (a) [17] N/A oral SR 10.1 No
Wetli (b) [17] N/A N/A 10.8 No
Horisberger [18] N/A N/A 17.7 Yes
Su (a) [19] 1000 oral SR 9.7 Yes
Illingworth (a) [20] 168 oral SR 9.1 Yes
Illingworth (b) [20] 320 oral SR 9.3 Yes
Illingworth (c) [20] oral SR 8.9 Yes
Steedman [21] 480 oral SR 9.1 Yes
Höjer [22] 1000 oral SR 9.2 Yes
Bosse [23] oral SR 11 Yes
Nilsson [24] 300 oral SR 10.3 Yes
Iijama [25] 240 oral SR 7.0 Yes
Madan (a) [26] 239 oral 1 9.4 Yes
Madan (b) [26] 1237 oral 1 9 Yes
Madan (c) [26] 798 oral 1 8.4 Yes
Madan (d) [26] 1601 oral 1 8.2 Yes

1 not specified, RoA: Route of administration, IV: intravenous, SR: slow-release, AM: ante-mortem, N/A: no data available.